MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
450.45%
Quick Ratio
450.45%
Cash Ratio
141.24%
Debt to Asset Ratio
35.19%
Unit: Thousand (K) dollars
Assets Breakdown
    • Available-for-sale marketable se...
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in-capital
    • Accumulated deficit
    • Non-current portion of operating...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Cash and cash equivalents
39,028
25,306
32,773
26,850
Available-for-sale marketable securities
81,636
114,856
151,341
178,143
Accounts receivable
0
0
960
873
Prepaid expenses and other current assets
3,804
4,396
4,746
5,815
Total current assets
124,468
144,558
189,820
211,681
Property and equipment, net
9,896
11,160
13,895
15,113
Long-term investments
2,154
2,154
2,154
2,154
Operating lease right-of-use assets
31,772
33,761
36,011
37,283
Other assets
1,018
927
809
805
Restricted cash
4,393
4,393
5,248
5,248
Total assets
173,701
196,953
247,937
272,284
Accounts payable
2,603
2,398
1,215
2,891
Accrued expenses and other current liabilities
7,596
4,690
9,897
5,924
Current portion of operating lease liabilities
6,235
6,105
5,571
5,508
Deferred revenue
11,198
9,306
12,900
18,942
Total current liabilities
27,632
22,499
29,583
33,265
Non-current portion of operating lease liabilities
31,485
33,081
36,092
37,482
Deferred revenue, non-current
0
1,635
1,896
3,553
Other non-current liabilities
2,017
1,953
1,919
2,153
Total liabilities
61,134
59,168
69,490
76,453
Common stock 0.0001 par value 500,000,000 shares authorized 37,777,105 and 37,620,668 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
4
4
4
4
Additional paid-in-capital
474,096
471,754
466,414
463,404
Accumulated other comprehensive income (loss)
-122
-44
371
372
Accumulated deficit
-361,411
-333,929
-288,342
-267,949
Total stockholders' equity
112,567
137,785
178,447
195,831
Total liabilities and stockholders' equity
173,701
196,953
247,937
272,284
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Available-for-sale marketablesecurities$81,636K (-54.17%↓ Y/Y)Cash and cashequivalents$39,028K (45.36%↑ Y/Y)Prepaid expenses andother current assets$3,804K (-34.58%↓ Y/Y)Total current assets$124,468K (-41.20%↓ Y/Y)Operating leaseright-of-use assets$31,772K (-14.78%↓ Y/Y)Property and equipment,net$9,896K (-34.52%↓ Y/Y)Restricted cash$4,393K (-16.29%↓ Y/Y)Long-term investments$2,154K (0.00%↑ Y/Y)Other assets$1,018K (26.46%↑ Y/Y)Total assets$173,701K (-36.21%↓ Y/Y)Total liabilities andstockholders' equity$173,701K (-36.21%↓ Y/Y)Total stockholders'equity$112,567K (-42.52%↓ Y/Y)Total liabilities$61,134K (-20.04%↓ Y/Y)Accumulated deficit-$361,411K (-34.88%↓ Y/Y)Accumulated othercomprehensive income (loss)-$122K (-132.80%↓ Y/Y)Additionalpaid-in-capital$474,096K (2.31%↑ Y/Y)Non-current portion ofoperating lease...$31,485K (-16.00%↓ Y/Y)Total currentliabilities$27,632K (-16.93%↓ Y/Y)Other non-currentliabilities$2,017K (-6.32%↓ Y/Y)Common stock 0.0001 parvalue 500,000,000...$4K (0.00%↑ Y/Y)Deferred revenue$11,198K (-40.88%↓ Y/Y)Accrued expenses andother current...$7,596K (28.22%↑ Y/Y)Current portion ofoperating lease...$6,235K (13.20%↑ Y/Y)Accounts payable$2,603K (-9.96%↓ Y/Y)

Metagenomi Therapeutics, Inc. (MGX)

Metagenomi Therapeutics, Inc. (MGX)